SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001104659-16-159299
Filing Date
2016-11-28
Accepted
2016-11-28 16:15:47
Documents
4

Document Format Files

Seq Description Document Type Size
1 POS AM a16-22214_1posam.htm POS AM 253561
2 EX-23.1 a16-22214_1ex23d1.htm EX-23.1 2494
3 GRAPHIC g222141gai001.gif GRAPHIC 8926
4 GRAPHIC g222141bei001.jpg GRAPHIC 3774
  Complete submission text file 0001104659-16-159299.txt   274805
Mailing Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355
Business Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355 484-321-5554
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-212095 | Film No.: 162020078
SIC: 2834 Pharmaceutical Preparations